SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-12-012319
Filing Date
2012-03-01
Accepted
2012-03-01 15:50:35
Documents
1
Group Members
AUGUSTINE LAWLORCHRISTOPHER MIRABELLI, PH.D.HAROLD R. WERNERHEALTHCARE PARTNERS VIII, L.P.HEALTHCARE PARTNERS VIII, LLCJAMES H. CAVANAUGH, PH.D.JOHN W. LITTLECHILD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G v304492_sc13g-a.htm SC 13G/A 153705
  Complete submission text file 0001144204-12-012319.txt   155480
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Subject) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81377 | Film No.: 12657232
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 NASSAU STREET PRINCETON NJ 08542
Business Address 44 NASSAU STREET PRINCETON NJ 08542 609-430-3913
HealthCare Ventures VIII, L.P. (Filed by) CIK: 0001358990 (see all company filings)

IRS No.: 841684310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A